Also known as آسٹیوپوروسس مینجمنٹ
Cardiologist
M.B.B.S., F.C.P.S., MRCP
Internal Medicine Specialist
MBBS, Diploma in Internal Medicine, Certified in Diabetes, Certified in Endocrinology
Internal Medicine Specialist
MBBS, Diploma in Internal Medicine, Certified in Diabetes, Certified in Endocrinology
Internal Medicine Specialist
MBBS (Pb), MRCP (UK), FRCP (Glasgow), FRCP (Ireland), FRCP (London), FRCP (Edin), Ph.D (WA), Post Doc (Oxford)
Internal Medicine Specialist
MBBS (Pb), MRCP (UK), FRCP (Glasgow), FRCP (Ireland), FRCP (London), FRCP (Edin), Ph.D (WA), Post Doc (Oxford)
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Diabetologist
M.B.B.S, F.C.P.S (Medicine), M.R.C.P. (Medicine), OJT (England)
Diabetologist
M.B.B.S, F.C.P.S (Medicine), M.R.C.P. (Medicine), OJT (England)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
M.D, M.R.C.P. (UK), FACP (USA)
Dermatologist
MBBS, FCPS (Dermatology), MCPS (Medicine)
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine), MRCEM
Endocrinologist
M.B.B.S, F.C.P.S. (Medicine), F.C.P.S. (Endocrinology)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures